Delivery Order SPE2DB22D1106-SPE2DB24FDUR3
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,118.90, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,035.14 Firm Fixed Price Delivery Order contract is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the pharmaceutical product BARHEMSYS 5 MG/2 ML VIAL 2ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.69 firm-fixed-price delivery order has a completion date of September 22, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is a delivery order valued at $2,389.47 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, to support military healthcare programs globally. The IDC provides a comprehensive vehicle for AmerisourceBergen to deliver a range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a ceiling value of $28,487.26 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $5,937.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN4E3, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,237.80, is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The award does not have a set-aside designation, indicating it was competitively bid. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
This federal contract award, valued at $1,483.51, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,625.28, is a delivery order for pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...